Filing Details

Accession Number:
0001179110-15-009852
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-16 11:06:12
Reporting Period:
2015-06-15
Filing Date:
2015-06-16
Accepted Time:
2015-06-16 11:06:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
855654 Immunogen Inc IMGN Pharmaceutical Preparations (2834) 042726691
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1220049 Nicole Onetto Ontario Institute For Cancer Research
101 College Street, Suite 800
Toronto A6 M5G 0A3
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-06-15 3,211 $7.82 3,211 No 4 M Direct
Common Stock Disposition 2015-06-15 3,211 $13.86 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock option (right to buy) Disposition 2015-06-15 3,211 $7.82 3,211 $7.82
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,000 2011-02-01 2020-11-16 No 4 M Direct
Footnotes
  1. Exercisable as to 1,553 shares commencing on February 1, 2011, 1,553 shares commencing on May 1, 2011, 1,552 shares commencing on August 1, 2011 and 1,553 shares commencing on November 1, 2011, contingent upon the individual remaining a director as of each vesting date.
  2. Weighted average price of shares sold